Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

dc.contributor.author	Yusuf, Salim
dc.contributor.author	Islam, Shofiqul
dc.contributor.author	Chow, Clara K.
dc.contributor.author	Rangarajan, Sumathy
dc.contributor.author	Rahman, Omar
dc.contributor.author	et al
dc.date.accessioned	2013-03-31T13:15:45Z
dc.date.available	2013-03-31T13:15:45Z
dc.date.issued	2011-08-28
dc.description.abstract	The research was aimed to assess use of proven eff ective secondary preventive drugs (antiplatelet drugs, β blockers, angiotensin-converting-enzyme [ACE] inhibitors or angiotensin-receptor blockers [ARBs], and statins) in individuals with a history of coronary heart disease or stroke.
dc.identifier.citation	Yusuf, S. et al (2011). Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet, 378: pp.1231-1243
dc.identifier.other	https://ar.iub.edu.bd/handle/11348/166
dc.identifier.uri	https://ar.iub.edu.bd/handle/11348/166
dc.language.iso	en
dc.publisher	Lancet
dc.source	IUB Academic Repository
dc.subject	Cardiovascular disease
dc.subject	Epidemiology
dc.subject	Surveys
dc.subject	Drugs
dc.subject	Income levels
dc.subject	Rural areas
dc.subject	Urban Areas
dc.subject	Angiotensin
dc.title	Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
dc.type	Article

Files

Now showing 1 - 1 of 1